Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage

Figure 3 MPO (A), MDA (B) and GSH (C) levels in the gastric mucosa of rats treated with indomethacin (IND, 100 µmol/kg) or piroxicam (PIR, 150 µmol/kg), either alone or in the presence of lansoprazole (LAN, 90 µmol/kg). Each column represents the mean value obtained from 7 to 10 animals ± SE. ^aP < 0.05 vs control values; ^cP < 0.05 between the respective values obtained in animals treated with indomethacin or piroxicam alone.